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Open access undIntroduction
Carcinosarcomas, formerly malignant mixed Müllerian tumors
(MMMTs), of the fallopian tube are extremely rare. From the world
literature we have compiled and reviewed 80 cases of carcinosarcoma
of the fallopian tube and present an additional case of a 57 year old
Caucasian female diagnosed with stage IIIA heterologous carcinosar-
coma with an unusual presentation displayed in Table S1.
The most common site of carcinosarcomas in the female genital
tract is the endometrium, whereas carcinosarcomas arising in the fal-
lopian tube are so rare that it has been recommended that each case be
reported [1]. These highly aggressive tumors are composed of both ep-
ithelial and stromal elements. They usually present in the ﬁfth to sixth
decades in postmenopausal women. Preoperative imaging diagnosis
of fallopian tube malignancy is rare because of features similar to
those of hydrosalpinx, tuboovarian abscess, and ovarian neoplasms.
The most common presenting symptom is abdominal pain followed
by atypical vaginal bleeding and abdominal distension [2]. We were
unable to ﬁnd any other previously reported cases presenting with
torsion, rupture and hemoperitoneum.bstetrics and Gynecology, Akron General
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A 57 year old postmenopausal Gravida 3, Para 3 Caucasian female
presented to the hospital on January 7, 2011 with severe intermittent
lower abdominal pain of several days duration. Physical examination
revealed tenderness and rebound in the suprapubic region. Adequate
bowel sounds were noted and the remainder of the physical exam
was negative. A CT of the abdomen and pelvis with contrast revealed
complex ascites suggestive of hemoperitoneum. A 10.0×6.5 cm com-
plex pelvic mass was seen anterior to the uterine fundus. The patient
underwent exploratory laparotomy and approximately 800 ml of
blood was identiﬁed. A large tumor of the distal left fallopian tube,
had undergone torsion and rupture with subsequent bleeding.
Tumor involvement of the cul-de-sac and right ovary required total
abdominal hysterectomy, bilateral salpingo-oophorectomy, omen-
tectomy, tumor reductive surgery, and pelvic lymph node dissections.
There was no gross residual disease.
Pathologic diagnosis revealed a heterologous carcinosarcoma aris-
ing from the left fallopian tube. Gross description: The distal left fallo-
pian tube contained a congested, edematous, and hemorrhagic
segment with tumor measuring 10×10×5 cm. Tumor fragments
were attached to the cul-de-sac and posterior cervix measuring
3×3×1.5 cm. Histologic description: The tumor consisted mostly of
an epithelial component with serous papillary features and an undif-
ferentiated stromal component. A prominent component of malig-
nant cartilage was also identiﬁed (Fig. 1). Features were consistent
with origin from the left distal fallopian tube with associated torsion
and hemorrhage. Microscopically, the omentum, pelvic peritoneum,
and right ovary contained metastatic carcinosarcoma. The right oviduct,
left ovary, uterus and bilateral pelvic lymphnodeswere negative forma-
lignancy. Fluid cytology was positive for malignant cells. Pathologic
stage was IIIA.
Immunohistochemical analysis revealed the epithelial component to
be positive for pankeratin. Both the stromal and epithelial components
were positive for vimentin. The epithelial and stromal components
were both focally positive for desmin and smooth-muscle actin. In
regards to CD 10 expression, the stromal component was strongly posi-
tive (Fig. 2A), while the epithelial component was positive (Fig. 2B).
The patient received combination chemotherapy consisting of
doxorubicin, 45 mg/ m2; cisplatin, 50 mg/m2; and paclitaxel,
160 mg/m2 at three week intervals for six cycles. Pre-operative CA-
125 level was elevated at 58.7 U/mL, which decreased to 21.3 U/mL
one month after surgery and to 7.1 U/mL following her last
Fig. 1. Carcinosarcoma with epithelial and stromal components as well as a component
of cartilage.
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ing or physical examination 8 months after surgical resection.
Discussion
Eighty cases of carcinosarcoma of the fallopian tube have been pre-
viously reported in the literature. Our compilation of these cases, in-
cluding our own, is summarized in Table S1. Our review of theseFig. 2. A: Immunohistochemistry for CD10,with strong stainingof the stromal component.
B: Immunohistochemistry for CD10, with positive staining of the epithelial component.cases provides similar conclusions regarding usual presenting symp-
toms, tumor nature, metastasis, and treatments as previously reported
[2]. The average age was 59.7 years and the most common presenting
symptom was abdominal pain followed by atypical bleeding. With our
additional case, there have been 34 and 47 reported homologous and
heterologous cases respectively. Among the heterologous cases, the
most common sarcomatous component was chondrosarcoma (70%),
followed by rhabdomyosarcoma (28%), and osteosarcoma (6%). All of
the cases that had a mixture of sarcomatous components contained
chondrosarcoma. The most common site of metastasis, besides non-
speciﬁcally within the pelvis, was to the ovaries and the omentum. Cy-
clophosphamidewas themost common agent used in combination che-
motherapy followed by doxorubicin and cisplatin.
Within the female genital tract the fallopian tube is a rare site for
primary carcinoma, and is also the least common location for carcino-
sarcomas. Previous reports indicate fallopian tubes as the origin of
less than 4% of all gynecologic carcinosarcomas [1]. It has been sug-
gested that immunohistochemical staining of the carcinomatous and
sarcomatous elements to both cytokeratin and vimentin or SMA is the
gold standard for diagnosis [3]. The expression of CD 10 in the present
case is consistent with previous reports that propose it as a characteristic
of Müllerian system derived neoplastic mesenchymal cells [4].
Reports on imaging carcinosarcomas of the fallopian tube are
scarce, however, it was reported that compared to carcinoma of the
fallopian tube, carcinosarcoma had a heterogeneous signal on MR
compared to a homogenous signal in carcinoma [5]. This could sug-
gest that MR should be used over CT to not only localize the origin
of a pelvic mass but also to determine certain imaging characteristics
that may assist in the preoperative diagnosis of a fallopian tube carci-
nosarcoma. Follow-up PET/CT imaging, in combination with CA-125
and physical examination may be superior to CT alone to evaluate re-
currence of fallopian tube cancer and may prevent the need for inva-
sive surgical assessment [6]. Carcinosarcoma of the fallopian tube
may rarely present as a surgical emergency, with torsion and rupture
leading to hemoperitoneum. Because of the uncommon occurrence of
fallopian tube carcinosarcoma, reporting cases as they are encoun-
tered and providing follow-up details will allow for more under-
standing in regards to diagnostic and treatment efﬁcacy.
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